Clinical Trial Update: A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating CI-1033 for metastatic breast cancer has completed. The update notes the trial status but does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CI-1033

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED